# A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients

> **NCT04974190** · NA · UNKNOWN · sponsor: **The Grasses of Eden Ltd** · enrollment: 550 (estimated)

## Conditions studied

- COVID-19 Infection

## Interventions

- **DEVICE:** Nasal Spray Device

## Key facts

- **NCT ID:** NCT04974190
- **Lead sponsor:** The Grasses of Eden Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08
- **Primary completion:** 2021-10
- **Final completion:** 2022-02
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2021-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04974190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04974190, "A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04974190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*